← Back to directory

Paolo Nucíforo

Researcher Next ID · RN-035247

Researcher · Biochemistry, Genetics and Molecular Biology

Vall d'Hebron Institut de Recerca

Barcelona, Spain

Accepting doctoral researchersFunding unknown
Works count
883
Citation count
20,292
H-index
73
i10-index
166

Research interests

Biochemistry, Genetics and Molecular Biology
Medicine
HER2/EGFR in Cancer Research
Cancer Genomics and Diagnostics
Cancer Immunotherapy and Biomarkers
Advanced Breast Cancer Therapies
Monoclonal and Polyclonal Antibodies Research

Publications

  • The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology

    Nature Cancer · 2022 · https://doi.org/10.1038/s43018-022-00332-x

  • A CT-based Radiomics Signature Is Associated with Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors

    Radiology · 2021 · https://doi.org/10.1148/radiol.2021200928

  • LIF regulates CXCL9 in tumor-associated macrophages and prevents CD8+ T cell tumor-infiltration impairing anti-PD1 therapy

    Nature Communications · 2019 · https://doi.org/10.1038/s41467-019-10369-9

  • HER2-Enriched Subtype and ERBB2 Expression in HER2-Positive Breast Cancer Treated with Dual HER2 Blockade

    JNCI Journal of the National Cancer Institute · 2019 · https://doi.org/10.1093/jnci/djz042

  • RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancer

    Annals of Oncology · 2018 · https://doi.org/10.1093/annonc/mdy099

  • Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non–Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors

    Advances in Anatomic Pathology · 2017 · https://doi.org/10.1097/pap.0000000000000161

  • Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma In Situ, Metastatic Tumor Deposits and Areas for Further Research

    Advances in Anatomic Pathology · 2017 · https://doi.org/10.1097/pap.0000000000000162

  • Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer

    Science · 2017 · https://doi.org/10.1126/science.aal5240

  • Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non–Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourina

    Advances in Anatomic Pathology · 2017 · https://doi.org/10.1097/pap.0000000000000161

  • Concordance of blood- and tumor-based detection of RAS mutations to guide anti-EGFR therapy in metastatic colorectal cancer

    Annals of Oncology · 2017 · https://doi.org/10.1093/annonc/mdx112

  • mTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancer

    Nature · 2017 · https://doi.org/10.1038/nature22964

  • Immune-Related Gene Expression Profiling After PD-1 Blockade in Non–Small Cell Lung Carcinoma, Head and Neck Squamous Cell Carcinoma, and Melanoma

    Cancer Research · 2017 · https://doi.org/10.1158/0008-5472.can-16-3556

  • Tumor-Infiltrating Lymphocytes and Associations With Pathological Complete Response and Event-Free Survival in HER2-Positive Early-Stage Breast Cancer Treated With Lapatinib and Trastuzumab

    JAMA Oncology · 2015 · https://doi.org/10.1001/jamaoncol.2015.0830

  • PIK3CA Mutations Are Associated With Decreased Benefit to Neoadjuvant Human Epidermal Growth Factor Receptor 2–Targeted Therapies in Breast Cancer

    Journal of Clinical Oncology · 2015 · https://doi.org/10.1200/jco.2014.55.2158

  • Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaboration

    Annals of Oncology · 2015 · https://doi.org/10.1093/annonc/mdv161

  • Genomic aberrations in the FGFR pathway: opportunities for targeted therapies in solid tumors

    Annals of Oncology · 2013 · https://doi.org/10.1093/annonc/mdt419

  • NUMB controls p53 tumour suppressor activity

    Nature · 2008 · https://doi.org/10.1038/nature06412

  • Mitf regulation of Dia1 controls melanoma proliferation and invasiveness

    Genes & Development · 2006 · https://doi.org/10.1101/gad.406406

  • Frequent Alterations in the Expression of Serine/Threonine Kinases in Human Cancers

    Cancer Research · 2006 · https://doi.org/10.1158/0008-5472.can-05-3489

  • Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication

    Nature · 2006 · https://doi.org/10.1038/nature05327

Current projects

    No projects listed.